1. Nasal absorption in the rat: IV. Membrane activity of absorption enhancers
- Author
-
N.W. Thomas, Lisbeth Illum, and Susan G. Chandler
- Subjects
Nasal cavity ,Chemistry ,Pharmaceutical Science ,Biological activity ,Absorption (skin) ,Pharmacology ,Haemolysis ,Nasal Absorption ,medicine.anatomical_structure ,Mechanism of action ,Biochemistry ,In vivo ,medicine ,Membrane activity ,lipids (amino acids, peptides, and proteins) ,medicine.symptom - Abstract
An erythrocyte model has been used to investigate the membrane activity of various agents which have been employed as enhancers of intranasal drug absorption. Enhancers were ranked according to haemolytic activity as follows: LPC-stearoyl > laureth-9 > STDHF > LPC-decanoyl > LPC-caproyl = DEAE-dextran = PBS (pH 7.0). The concentrations known to significantly enhance nasal absorption were generally, though not exclusively, in excess of that causing haemolysis, suggesting that membrane activity is involved in their mechanism of action, but that other mechanisms may also be important. In some cases, the effects on the erythrocyte membrane contrasted with those observed on the nasal epithelium in vivo, indicating the influence of the local environment of the nasal cavity on the activity of enhancing agents and the importance of histological studies in vivo.
- Published
- 1995